Skip to main content
Top
Published in: Radiation Oncology 1/2017

Open Access 01-12-2017 | Research

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers

Authors: Kentaro Nishioka, Shinichi Shimizu, Nobuo Shinohara, Yoichi M. Ito, Takashige Abe, Satoru Maruyama, Norio Katoh, Rumiko Kinoshita, Takayuki Hashimoto, Naoki Miyamoto, Rikiya Onimaru, Hiroki Shirato

Published in: Radiation Oncology | Issue 1/2017

Login to get access

Abstract

Background

Current adaptive and dose escalating radiotherapy for muscle invasive bladder cancer requires knowledge of both inter-fractional and intra-fractional motion of the bladder wall involved. The purpose of this study is to characterize inter- and intra-fractional movement of the partial bladder wall using implanted fiducial markers and a real-time tumor-tracking radiotherapy system.

Methods

Two hundred fifty one sessions with 29 patients were analysed. After maximal transurethral bladder tumor resection and 40 Gy of whole bladder irradiation, up to six gold markers were implanted transurethrally into the bladder wall around the tumor bed and used for positional registration. We compared the systematic and random uncertainty of positions between cranial vs. caudal, left vs. right, and anterior vs. posterior tumor groups. The variance in intrafractional movement and the percentage of sessions where 3 mm and 5 mm or more of intrafractional wall movement occurring at 2, 4, 6, 8, 10, and at more than 10 min until the end of a session were determined.

Results

The cranial and anterior tumor group showed larger interfractional uncertainties in the position than the opposite side tumor group in the CC and AP directions respectively, but these differences did not reach significance. Among the intrafractional uncertainty of position, the cranial and anterior tumor group showed significantly larger systematic uncertainty of position than the groups on the opposite side in the CC direction. The variance of intrafractional movement increased over time; the percentage of sessions where intrafractional wall movement was larger than 3 mm within 2 min of the start of a radiation session or larger than 5 mm within 10 min was less than 5%, but this percentage was increasing further during the session, especially in the cranial and anterior tumor group.

Conclusions

More attention for intrafractional uncertainty of position is required in the treatment of cranial and anterior bladder tumors especially in the CC direction. The optimal internal margins in each direction should be chosen or a precise intrafractional target localization system is required depending on the tumor location and treatment delivery time in the setting of partial bladder radiotherapy.
Literature
1.
go back to reference Shipley W, Zietman A, Kaufman D, Coen J, Sandler H. Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates-The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol. 2005;15:36–41.CrossRefPubMed Shipley W, Zietman A, Kaufman D, Coen J, Sandler H. Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates-The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol. 2005;15:36–41.CrossRefPubMed
2.
go back to reference Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61:705–11.CrossRefPubMed Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61:705–11.CrossRefPubMed
3.
go back to reference Perdonà S, Autorino R, Damiano R, De Sio M, Morrica B, Gallo L, Silvestro G, Farella A, De Placido S, Di Lorenzo G. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience. Cancer. 2008;112:75–83.CrossRefPubMed Perdonà S, Autorino R, Damiano R, De Sio M, Morrica B, Gallo L, Silvestro G, Farella A, De Placido S, Di Lorenzo G. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience. Cancer. 2008;112:75–83.CrossRefPubMed
4.
go back to reference Rodel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol. 2006;24:5536–44.CrossRefPubMed Rodel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol. 2006;24:5536–44.CrossRefPubMed
5.
go back to reference Pos FJ, Hart G, Schneider C, Sminia P. Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose? Int J Radiat Oncol Biol Phys. 2006;64:1168–73.CrossRefPubMed Pos FJ, Hart G, Schneider C, Sminia P. Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose? Int J Radiat Oncol Biol Phys. 2006;64:1168–73.CrossRefPubMed
6.
go back to reference Cowan RA, McBain CA, Ryder WDJ, Wylie JP, Logue JP, Turner SL, Van der Voet J, Collins CD, Khoo VS, Read GR. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:197–207.CrossRefPubMed Cowan RA, McBain CA, Ryder WDJ, Wylie JP, Logue JP, Turner SL, Van der Voet J, Collins CD, Khoo VS, Read GR. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:197–207.CrossRefPubMed
7.
go back to reference Hafeez S, Warren-Oseni K, McNair HA, Hansen VN, Jones K, Tan M, Khan A, Harris V, McDonald F, Lalondrelle S, Mohammed K, Thomas K, Thompson A, Kumar P, Dearnaley D, Horwich A, Huddart R. Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) with Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016;94:1022–30.CrossRefPubMed Hafeez S, Warren-Oseni K, McNair HA, Hansen VN, Jones K, Tan M, Khan A, Harris V, McDonald F, Lalondrelle S, Mohammed K, Thomas K, Thompson A, Kumar P, Dearnaley D, Horwich A, Huddart R. Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) with Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2016;94:1022–30.CrossRefPubMed
8.
go back to reference Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, Crundwell M, Adab FA, Sheehan D, Syndikus I, Hendron C, Lewis R, Waters R, James ND. Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004). Int J Radiat Oncol Biol Phys. 2013;87:261–9.CrossRefPubMedPubMedCentral Huddart RA, Hall E, Hussain SA, Jenkins P, Rawlings C, Tremlett J, Crundwell M, Adab FA, Sheehan D, Syndikus I, Hendron C, Lewis R, Waters R, James ND. Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004). Int J Radiat Oncol Biol Phys. 2013;87:261–9.CrossRefPubMedPubMedCentral
9.
go back to reference Murthy V, Masodkar R, Kalyani N, Mahantshetty U, Bakshi G, Prakash G, Joshi A, Prabhash K, Ghonge S, Shrivastava S. Clinical outcomes with dose-escalated adaptive radiation therapy for urinary bladder cancer: A prospective study. Int J Radiat Oncol Biol Phys. 2016;94:60–6.CrossRefPubMed Murthy V, Masodkar R, Kalyani N, Mahantshetty U, Bakshi G, Prakash G, Joshi A, Prabhash K, Ghonge S, Shrivastava S. Clinical outcomes with dose-escalated adaptive radiation therapy for urinary bladder cancer: A prospective study. Int J Radiat Oncol Biol Phys. 2016;94:60–6.CrossRefPubMed
10.
go back to reference Muren LP, Redpath AT, Lord H, McLaren D. Image-guided radiotherapy of bladder cancer: bladder volume variation and its relation to margins. Radiother Oncol. 2007;84:307–13.CrossRefPubMed Muren LP, Redpath AT, Lord H, McLaren D. Image-guided radiotherapy of bladder cancer: bladder volume variation and its relation to margins. Radiother Oncol. 2007;84:307–13.CrossRefPubMed
11.
go back to reference McBain CA, Green MM, Stratford J, Davies J, McCarthy C, Taylor B, McHugh D, Swindell R, Khoo V, Price P. Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool. Clin Oncol (R Coll Radiol). 2009;21:385–93.CrossRef McBain CA, Green MM, Stratford J, Davies J, McCarthy C, Taylor B, McHugh D, Swindell R, Khoo V, Price P. Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool. Clin Oncol (R Coll Radiol). 2009;21:385–93.CrossRef
12.
go back to reference McBain CA, Khoo VS, Buckley DL, Sykes JS, Green MM, Cowan RA, Hutchinson CE, Moore CJ, Price PM. Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;75:664–71.CrossRefPubMed McBain CA, Khoo VS, Buckley DL, Sykes JS, Green MM, Cowan RA, Hutchinson CE, Moore CJ, Price PM. Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;75:664–71.CrossRefPubMed
13.
go back to reference Turner SL, Swindell R, Bowl N, Marrs J, Brookes B, Read G, Cowan RA. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys. 1997;39:355–60.CrossRefPubMed Turner SL, Swindell R, Bowl N, Marrs J, Brookes B, Read G, Cowan RA. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys. 1997;39:355–60.CrossRefPubMed
14.
go back to reference Harris SJ, Buchanan RB. An audit and evaluation of bladder movements during radical radiotherapy. Clin Oncol. 1998;10:262–64.CrossRef Harris SJ, Buchanan RB. An audit and evaluation of bladder movements during radical radiotherapy. Clin Oncol. 1998;10:262–64.CrossRef
15.
go back to reference Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol. 2003;69:291–304.CrossRefPubMed Muren LP, Smaaland R, Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol. 2003;69:291–304.CrossRefPubMed
16.
go back to reference Meijer G, Rasch C, Remeijer P, Lebesque J. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol. 2003;55:1277–87.CrossRef Meijer G, Rasch C, Remeijer P, Lebesque J. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol. 2003;55:1277–87.CrossRef
17.
go back to reference Della Biancia C, Yorke E, Kollmeier MA. Image guided radiation therapy for bladder cancer: assessment of bladder motion using implanted fiducial markers. Pract Radiat Oncol. 2014;4:108–15.CrossRefPubMed Della Biancia C, Yorke E, Kollmeier MA. Image guided radiation therapy for bladder cancer: assessment of bladder motion using implanted fiducial markers. Pract Radiat Oncol. 2014;4:108–15.CrossRefPubMed
18.
go back to reference Zietman AL, Sacco D, Skowronski U, Gomery P, Kaufman DS, Clark JA, Talcott JA, Shipley WU. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol. 2003;170:1772–76.CrossRefPubMed Zietman AL, Sacco D, Skowronski U, Gomery P, Kaufman DS, Clark JA, Talcott JA, Shipley WU. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol. 2003;170:1772–76.CrossRefPubMed
19.
go back to reference Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, Sandler HM. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06. J Clin Oncol. 2009;27:4055–61.CrossRefPubMedPubMedCentral Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, Sandler HM. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06. J Clin Oncol. 2009;27:4055–61.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Shimizu S, Shirato H, Kitamura K, Shinohara N, Harabayashi T, Tsukamoto T, Koyanagi T, Miyasaka K. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys. 2000;48:1591–97.CrossRefPubMed Shimizu S, Shirato H, Kitamura K, Shinohara N, Harabayashi T, Tsukamoto T, Koyanagi T, Miyasaka K. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys. 2000;48:1591–97.CrossRefPubMed
22.
go back to reference Mangar SA, Scurr E, Huddart RA, Sohaib SA, Horwich A, Dearnaley DP, Khoo VS. Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer. Radiother Oncol. 2007;85:207–14.CrossRefPubMed Mangar SA, Scurr E, Huddart RA, Sohaib SA, Horwich A, Dearnaley DP, Khoo VS. Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer. Radiother Oncol. 2007;85:207–14.CrossRefPubMed
23.
go back to reference Thariat J, Aluwini S, Pan Q, Caullery M, Marcy P-Y, Housset M, Lagrange J-L. Image-guided radiation therapy for muscle-invasive bladder cancer. Nat Rev Urol. 2012;9:23–9.CrossRef Thariat J, Aluwini S, Pan Q, Caullery M, Marcy P-Y, Housset M, Lagrange J-L. Image-guided radiation therapy for muscle-invasive bladder cancer. Nat Rev Urol. 2012;9:23–9.CrossRef
24.
go back to reference Yee D, Parliament M, Rathee S, Ghosh S, Ko L, Murray B. Cone beam CT imaging analysis of interfractional variations in bladder volume and position during radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2010;76:1045–53.CrossRefPubMed Yee D, Parliament M, Rathee S, Ghosh S, Ko L, Murray B. Cone beam CT imaging analysis of interfractional variations in bladder volume and position during radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2010;76:1045–53.CrossRefPubMed
25.
go back to reference Burridge N, Amer A, Marchant T, Sykes J, Stratford J, Henry A, McBain C, Price P, Moore C. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys. 2006;66:892–7.CrossRefPubMed Burridge N, Amer A, Marchant T, Sykes J, Stratford J, Henry A, McBain C, Price P, Moore C. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys. 2006;66:892–7.CrossRefPubMed
26.
go back to reference Lalondrelle S, Huddart R, Warren-Oseni K, Hansen VN, McNair H, Thomas K, Dearnaley D, Horwich A, Khoo V. Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2011;79:705–12.CrossRefPubMed Lalondrelle S, Huddart R, Warren-Oseni K, Hansen VN, McNair H, Thomas K, Dearnaley D, Horwich A, Khoo V. Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2011;79:705–12.CrossRefPubMed
27.
go back to reference Murthy V, Master Z, Adurkar P, Mallick I, Mahantshetty U, Bakshi G, Tongaonkar H, Shrivastava S. “Plan of the day” adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol. 2011;99:55–60.CrossRefPubMed Murthy V, Master Z, Adurkar P, Mallick I, Mahantshetty U, Bakshi G, Tongaonkar H, Shrivastava S. “Plan of the day” adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol. 2011;99:55–60.CrossRefPubMed
28.
go back to reference Tuomikoski L, Collan J, Keyriläinen J, Visapää H, Saarilahti K, Tenhunen M. Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume. Radiother Oncol. 2011;99:61–6.CrossRefPubMed Tuomikoski L, Collan J, Keyriläinen J, Visapää H, Saarilahti K, Tenhunen M. Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume. Radiother Oncol. 2011;99:61–6.CrossRefPubMed
29.
go back to reference Foroudi F, Pham D, Bressel M, Gill S, Kron T. Intrafraction Bladder Motion in Radiation Therapy Estimated From Pretreatment and Posttreatment Volumetric Imaging. Int J Radiat Oncol Biol Phys. 2013;86:77–82.CrossRefPubMed Foroudi F, Pham D, Bressel M, Gill S, Kron T. Intrafraction Bladder Motion in Radiation Therapy Estimated From Pretreatment and Posttreatment Volumetric Imaging. Int J Radiat Oncol Biol Phys. 2013;86:77–82.CrossRefPubMed
30.
go back to reference Grønborg C, Vestergaard A, Høyer M, Söhn M, Pedersen EM, Petersen JB, Agerbæk M, Muren LP. Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer. Acta Oncol. 2015;54:1461–6.CrossRefPubMed Grønborg C, Vestergaard A, Høyer M, Söhn M, Pedersen EM, Petersen JB, Agerbæk M, Muren LP. Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer. Acta Oncol. 2015;54:1461–6.CrossRefPubMed
31.
go back to reference Dees-Ribbers HM, Betgen A, Pos FJ, Witteveen T, Remeijer P, van Herk M. Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders. Radiother Oncol. 2014;113:254–59.CrossRefPubMed Dees-Ribbers HM, Betgen A, Pos FJ, Witteveen T, Remeijer P, van Herk M. Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: A comparison of full and empty bladders. Radiother Oncol. 2014;113:254–59.CrossRefPubMed
32.
go back to reference Shirato H, Oita M, Fujita K, Shimizu S, Onimaru R, Uegaki S, Watanabe Y, Kato N, Miyasaka K. Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room. Int J Radiat Oncol Biol Phys. 2004;60:607–12.CrossRefPubMed Shirato H, Oita M, Fujita K, Shimizu S, Onimaru R, Uegaki S, Watanabe Y, Kato N, Miyasaka K. Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room. Int J Radiat Oncol Biol Phys. 2004;60:607–12.CrossRefPubMed
33.
go back to reference Shimizu S, Osaka Y, Shinohara N, Sazawa A, Nishioka K, Suzuki R, Onimaru R, Shirato H. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys. 2011;81:e393–9.CrossRefPubMed Shimizu S, Osaka Y, Shinohara N, Sazawa A, Nishioka K, Suzuki R, Onimaru R, Shirato H. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys. 2011;81:e393–9.CrossRefPubMed
34.
go back to reference Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Kinoshita R, Harada K, Nishikawa N, Miyamoto N, Onimaru R, Shirato H. Prospective Phase II Study of Image-guided Local Boost Using a Real-time Tumor-tracking Radiotherapy (RTRT) System for Locally Advanced Bladder Cancer. Jpn J Clin Oncol. 2014;44:28–35.CrossRefPubMed Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Kinoshita R, Harada K, Nishikawa N, Miyamoto N, Onimaru R, Shirato H. Prospective Phase II Study of Image-guided Local Boost Using a Real-time Tumor-tracking Radiotherapy (RTRT) System for Locally Advanced Bladder Cancer. Jpn J Clin Oncol. 2014;44:28–35.CrossRefPubMed
Metadata
Title
Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
Authors
Kentaro Nishioka
Shinichi Shimizu
Nobuo Shinohara
Yoichi M. Ito
Takashige Abe
Satoru Maruyama
Norio Katoh
Rumiko Kinoshita
Takayuki Hashimoto
Naoki Miyamoto
Rikiya Onimaru
Hiroki Shirato
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2017
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-017-0778-z

Other articles of this Issue 1/2017

Radiation Oncology 1/2017 Go to the issue